These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 4390316)

  • 1. Lincomycin. 8. 4'-Alkyl-1'-demethyl-4'-depropylclindamycins, potent antibacterial and antimalarial agents.
    Magerlein BJ; Kagan F
    J Med Chem; 1969 Sep; 12(5):780-4. PubMed ID: 4390316
    [No Abstract]   [Full Text] [Related]  

  • 2. [Lincomycin--a new antibiotic].
    Primavesi CA
    Arzneimittelforschung; 1967 Apr; 17(4):500-2. PubMed ID: 4386772
    [No Abstract]   [Full Text] [Related]  

  • 3. Lincomycin. 14. An improved synthesis and resolution of the antimalarial agent, 1'-demethyl-4'-depropyl-4'-(R)- and -(S)-pentylclindamycin hydrochloride (U-24, 729A).
    Magerlein BJ
    J Med Chem; 1972 Dec; 15(12):1255-9. PubMed ID: 4629012
    [No Abstract]   [Full Text] [Related]  

  • 4. [Antibacterial activity in vitro of a new rifamycin: rifamide].
    Monnier J; Bourse R
    Pathol Biol; 1968 Oct; 16(19):901-8. PubMed ID: 4972879
    [No Abstract]   [Full Text] [Related]  

  • 5. Recent developments in lincomycin research.
    Grady JE
    Int Z Klin Pharmakol Ther Toxikol; 1968; 1(6):533-8. PubMed ID: 4388454
    [No Abstract]   [Full Text] [Related]  

  • 6. [On the effect of hexetidine in vitro].
    Linzenmeier G
    Arzneimittelforschung; 1969 Feb; 19(2):164-7. PubMed ID: 4388760
    [No Abstract]   [Full Text] [Related]  

  • 7. Morphological changes of bacteria induced by chemotherapeutic agents. 3.
    Matsumae A
    J Antibiot (Tokyo); 1965 Sep; 18(5):233-42. PubMed ID: 4379209
    [No Abstract]   [Full Text] [Related]  

  • 8. [Treatment with maximal tolerated doses of antibiotics. II. Chloramphenicol, lincomycin, and other preparations].
    Vacek V; Hejzlar M; Stafová J
    Cas Lek Cesk; 1968; 107(44):1316-9. PubMed ID: 4971814
    [No Abstract]   [Full Text] [Related]  

  • 9. [Bacteriological and pharmacological properties of new cephalosperine antibiotics. II. Cephaloridine].
    Naumann P
    Arzneimittelforschung; 1967 Apr; 17(4):469-81. PubMed ID: 4386771
    [No Abstract]   [Full Text] [Related]  

  • 10. [Study of antibacterial and antifungal activity of lutenurine in experiments in vitro].
    Vichkanova SA; Adgina VV; Fedorchenko TS; Rudinchik MA
    Farmakol Toksikol; 1969; 32(5):620-3. PubMed ID: 4391463
    [No Abstract]   [Full Text] [Related]  

  • 11. [Biologically active analogues of dihydrostreptomycin, not containing guanidine groups, synthesized on the basis of dideguanylhydrostreptomycin].
    Lazareva EN; Golubev VN; Shneerson AN; Vasilenko OS
    Antibiotiki; 1968 Aug; 13(8):682-6. PubMed ID: 4176822
    [No Abstract]   [Full Text] [Related]  

  • 12. Cephaloridine: antimicrobial activity and pharmacologic behavior.
    Kaplan K; Reisberg BE; Weinstein L
    Am J Med Sci; 1967 Jun; 253(6):667-74. PubMed ID: 4381751
    [No Abstract]   [Full Text] [Related]  

  • 13. [Nalidixic acid].
    Pagnini G
    Antibiotica; 1967 Jun; 5(2):134-59. PubMed ID: 4389549
    [No Abstract]   [Full Text] [Related]  

  • 14. Chemistry and biochemistry of the neomycins. XVI. Synthesis and bioactivity of hexa-N-benzylneomycins.
    Shier WT; Rinehart KL
    J Antibiot (Tokyo); 1973 Oct; 26(10):547-50. PubMed ID: 4151940
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparative in vitro activity of amoxicillin and ampicillin against bacteria isolated from ill children.
    Marks MI
    Curr Ther Res Clin Exp; 1974 Oct; 16(10):1137-44. PubMed ID: 4154827
    [No Abstract]   [Full Text] [Related]  

  • 16. [Antibacterial effect of rifampicin and its chemotherapeutic properties in experiments on animals].
    Shorin VA; Shapovalova SP; Malkova IV
    Antibiotiki; 1974 Dec; 19(12):1084-8. PubMed ID: 4155605
    [No Abstract]   [Full Text] [Related]  

  • 17. [Value of rifampicin in treatment of the patients with bronchopulmonary lesions. A clinical-bacteriological study].
    Beeuwkes H; Buytendijk HJ; Maesen FP
    Arzneimittelforschung; 1969 Aug; 19(8):1283-5. PubMed ID: 4390183
    [No Abstract]   [Full Text] [Related]  

  • 18. [Antibacterial activity of lincomycin in diseases of the maxillofacial region].
    Gabka J
    Arzneimittelforschung; 1968 Nov; 18(11):1453-7. PubMed ID: 4387836
    [No Abstract]   [Full Text] [Related]  

  • 19. Desacetyl-rifamycins: preparation and antibacterial properties.
    Maggi N; Vigevani A; Pallanza R
    Experientia; 1968 Mar; 24(3):209-11. PubMed ID: 4969311
    [No Abstract]   [Full Text] [Related]  

  • 20. In-vitro comparison of erythromycin, lincomycin, and clindamycin.
    Phillips L; Fernandes R; Warren C
    Br Med J; 1970 Apr; 2(5701):89-90. PubMed ID: 4988120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.